High-Dose Wegovy Shows 27.7% Average Weight Loss While Maintaining Muscle

Novo Nordisk reported clinical findings showing that a high-dose Wegovy product delivered an average 27.7% weight loss while maintaining muscle, according to the analysis. The results are based on clinical data announced by the Danish pharmaceutical company for its higher-dose Wegovy product. The original report also noted that even when weight loss is slow in the early stage, continued treatment may still lead to meaningful effects. As the obesity treatment market increasingly weighs not only total weight loss but also muscle preservation, the data draws attention as evidence describing the effect of high-dose Wegovy. Source: mk.co.kr